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Abstract
Background:  Complex carbohydrate structures, glycans, are essential components of
glycoproteins, glycolipids, and proteoglycans. While individual glycan structures including the SSEA
and Tra antigens are already used to define undifferentiated human embryonic stem cells (hESC),
the whole spectrum of stem cell glycans has remained unknown. We undertook a global study of
the asparagine-linked glycoprotein glycans (N-glycans) of hESC and their differentiated progeny
using MALDI-TOF mass spectrometric and NMR spectroscopic profiling. Structural analyses were
performed by specific glycosidase enzymes and mass spectrometric fragmentation analyses.
Results: The data demonstrated that hESC have a characteristic N-glycome which consists of both
a constant part and a variable part that changes during hESC differentiation. hESC-associated N-
glycans were downregulated and new structures emerged in the differentiated cells. Previously
mouse embryonic stem cells have been associated with complex fucosylation by use of SSEA-1
antibody. In the present study we found that complex fucosylation was the most characteristic
glycosylation feature also in undifferentiated hESC. The most abundant complex fucosylated
structures were Lex and H type 2 antennae in sialylated complex-type N-glycans.
Conclusion: The N-glycan phenotype of hESC was shown to reflect their differentiation stage.
During differentiation, hESC-associated N-glycan features were replaced by differentiated cell-
associated structures. The results indicated that hESC differentiation stage can be determined by
direct analysis of the N-glycan profile. These results provide the first overview of the N-glycan
profile of hESC and form the basis for future strategies to target stem cell glycans.
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Background
During the last decade global genomics and proteomics
analyses of defined cell populations have revolutionized
our understanding of cell biology. Glycomics – the study
of global glycan expression profiles – has been predicted
to be a next step forward [1]. Glycans, the carbohydrate
units of glycoproteins, glycolipids, and proteoglycans, are
capable of great structural variation and their specific
molecular structures carry vast amounts of biological
information [2]. It has been estimated that more than half
of all cellular proteins are glycosylated [3], but little is
known of glycan structures in specific cell types. Glycans
linked to cell surface proteins and lipids form a dense
layer – the glycocalyx – on the extracellular side of the cell
surface. The glycocalyx has first-line functions in the com-
munication of the cell and its environment, including
both cell-to-cell contacts [2,4-6] and interactions with
extracellular matrix components [7]. In addition, the spe-
cific roles of N-glycans involve regulation and control of
protein folding [8,9] and trafficking [10].
Human embryonic stem cells (hESC) [11] provide models
for the study of human development and toxicology and
have therapeutic potential in regenerative medicine [12].
To effectively utilize these cells, novel differentiation stage
and lineage specific stem cell markers are required. Since
glycans are abundant components of the cell surface, rea-
gents that specifically recognize hESC glycans should be
useful tools for the identification, isolation, and manipu-
lation of stem cells. In fact, the monoclonal antibodies
currently used to define hESC, including the globo-series
glycosphingolipid epitopes SSEA-3 and SSEA-4, and the
keratanase-sensitive glycoprotein associated epitopes Tra
1–60 and Tra 1–81, recognize glycan antigens [13-15].
Further, the expansion of undifferentiated hESC and the
directed differentiation of hESC to specific progeny line-
ages in cell culture remain problematic. Understanding
how cells interact through the glycocalyx with feeder cells
and other components of the culture environment may
enable rational design of specific culture systems.
In the present study, a global analysis of the asparagine-
linked glycans (N-glycans) of hESC and cells differenti-
ated from them was performed by mass spectrometric
profiling of unmodified glycans. We found that hESC
have a characteristic and complex protein N-glycosylation
profile. The data provide insight into the glycobiology of
hESC and can be utilized as a basis for future studies
exploring the role of stem cell glycans.
Results
Analysis strategy
In order to generate mass spectrometric glycan profiles of
hESC, embryoid bodies (EB), and further differentiated
cells, a matrix-assisted laser desorption-ionization
(MALDI-TOF) mass spectrometry based analysis was per-
formed. We focused on the most common type of protein
post-translational modifications, N-glycans, which were
enzymatically released from cellular glycoproteins. Dur-
ing glycan isolation and purification, the total N-glycan
pool was separated by an ion-exchange step into neutral
N-glycans and sialylated N-glycans. These two glycan frac-
tions were then analyzed separately by mass spectrometric
profiling (Fig. 1 and 2), which yielded a global view of the
N-glycan repertoire and allowed comparative analysis of
differentiation-associated changes. The present scarce
sample amounts did not allow us to purify individual gly-
can components for structural analyses. However,
detailed structural analyses were achieved from the total
neutral and acidic N-glycan pools by a combination of
proton NMR spectroscopy, specific glycosidase digestions,
and MS/MS fragmentation experiments.
MALDI-TOF mass spectrometric analysis has been shown
to be accurate in relative quantitation of glycan compo-
nents within complex glycan mixtures [16]. We and others
have found that it is a powerful tool for comparing
changes in the glycan composition especially between
closely related samples [17-19]. The present MALDI-TOF
mass spectrometric methods have been optimized for rel-
ative quantitation of non-derivatized glycans and poten-
tially labile glycan residues such as sialic acids are reliably
determined. This was further verified during the present
work by comparison of non-derivatized and permethyl-
ated glycan samples. The relative proportions of the major
glycan signals were similar and no sialic acid or fucose loss
was detected (data not shown). Due to the large m/z range
of observed glycan ions the percentage of each glycan sig-
nal might not represent absolute molar percentage of the
total cellular N-glycome. The amounts of especially larger
glycans may be underestimated. However, we demon-
strated with standard molecules that over the m/z range
there was a linear response between the amount of added
analyte and its relative signal intensity in the recorded gly-
can profile (see Additional File 1, Supplementary Fig. 1).
Each step in the glycan purification sequence was control-
led for reproducibility by mixtures of glycoproteins, syn-
thetic glycans, and glycan mixtures extracted from human
cells. We routinely obtained the same mass spectrometric
profiles for the standard glycan mixtures after each purifi-
cation step during the multi-stage purification process
[18] showing that there was no selective loss of glycans
during purification. The yield of the N-glycosidase reac-
tion was over 95% with model glycoproteins. The robust-
ness of the present method was further evaluated by
subjecting human cell samples to blinded analysis by five
different persons. The results were highly comparable
showing that the present method reliably reproduced the
characteristic glycan profile of each cell type (see Addi-BMC Cell Biology 2009, 10:42 http://www.biomedcentral.com/1471-2121/10/42
Page 3 of 18
(page number not for citation purposes)
Mass spectrometric neutral N-glycan profile of human embryonic stem cells (hESC) Figure 1
Mass spectrometric neutral N-glycan profile of human embryonic stem cells (hESC). A. MALDI-TOF MS spectrum 
of neutral N-glycan fraction isolated from a hESC sample. B. Average of relative signal intensities from 40 most abundant neu-
tral N-glycans of four finnish hESC lines (blue columns), embryoid bodies derived from the hESC lines (EB, red columns), and 
stage 3 differentiated cells (st.3, white columns). The columns indicate the mean abundance of each glycan signal (% of the total 
detected glycan signals). Error bars represent the standard error of mean. Proposed monosaccharide compositions are indi-
cated on the x-axis and proposed structures for the major N-glycans are shown as schematic drawings. Gray circle/H: hexose, 
green circle: mannose, yellow circle: galactose, blue circle: glucose, gray square/N: N-acetylhexosamine, blue square: N-
acetylglucosamine, red triangle/F: fucose/deoxyhexose, violet diamond/S: N-acetylneuraminic acid, light blue diamond/G: N-gly-
colylneuraminic acid. Asterisks indicate known polyhexose contamination that was not included in panel B.BMC Cell Biology 2009, 10:42 http://www.biomedcentral.com/1471-2121/10/42
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Mass spectrometric acidic N-glycan profile of hESC Figure 2
Mass spectrometric acidic N-glycan profile of hESC. A. MALDI-TOF MS spectrum of acidic N-glycan fraction isolated 
from a hESC sample. B. Average of relative signal intensities from 40 most abundant sialylated N-glycans of the four hESC lines, 
EBs, and stage 3 differentiated cells. N-glycan signals carrying structural features associated with either hESC (F ≥ 2, red circles) 
or differentiated cells (N = H, gray circles) are indicated below panel B. See the legend of Figure 1 for details and monosaccha-
ride symbols.BMC Cell Biology 2009, 10:42 http://www.biomedcentral.com/1471-2121/10/42
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tional File 1, Supplementary Fig. 2). The glycan profile
was demonstrated to be reproducible also when different
dilutions of the same sample were analyzed, demonstrat-
ing that the results were not sensitive to the exact amount
of cells in each sample. However, in the present analyses
the cell amounts were comparable in the whole sample
series.
We analyzed N-glycan profiles of all the biological mate-
rials that were in contact with the stem cells and could
potentially contaminate the samples with glycoproteins,
including hEF and mEF feeder cells, cell culture media,
and culture media supplements. The N-glycan profiles
revealed that the employed cell harvesting and washing
procedures had been efficient and neither the feeder cells
nor the culture media glycoproteins had affected the
observed stem cell N-glycan profiles to a marked extent.
By comparing the characteristic glycan signals in each
potential contamination source, we could calculate that
N-glycan purity in the samples was at least 93%.
hESC N-glycan profiles
Neutral N-glycans comprised approximately two thirds of
the combined neutral and sialylated N-glycan pools of
hESC. The relative proportions of the two glycan pools
were analyzed by combining corresponding aliquots from
the neutral glycan pool and the acidic glycan pool after
broad-range sialidase digestion and comparing the com-
bined glycan profile to the separate neutral and acidic gly-
can profiles (data not shown).
The 40 most abundant neutral N-glycan signals detected
in the four hESC lines are presented in Figure 1B (blue col-
umns). The similarity of the profiles with the four hESC
lines, which is indicated by the minor variation in the gly-
can signals, suggests that the four cell lines closely resem-
bled each other. For example, 15 of the 20 most abundant
glycan signals were the same in every hESC line. The five
most abundant signals (H5N2, H6N2, H7N2, H8N2, and
H9N2) comprised 76% of the neutral N-glycan signals
and dominated the profile.
All the major N-glycan signals in the acidic N-glycan frac-
tion (Fig. 2B, blue columns) contained sialic acid resi-
dues. There was more variation between individual cell
lines in the 40 most abundant acidic N-glycans than in the
neutral N-glycans. However, the four hESC lines again
resembled each other and the five most abundant sia-
lylated N-glycan signals were the same in every cell line:
S1H5N4F1, S1H5N4F2, S2H5N4F1, S1H5N4, and
S1H6N5F1. The most abundant sialylated glycan signals
contained the H5N4 core composition and differed only
by variable number of sialic acid (S or G) and deoxyhex-
ose (F) residues. These biantennary-size N-glycans
together comprised 61% of the total glycan signal inten-
sity in the acidic glycan fraction.
We detected N-glycans containing N-glycolylneuraminic
acid (G) in the hESC samples, for example glycans
G1H5N4, G1S1H5N4, and G2H5N4. N-glycolyl-
neuraminic acid has previously been reported in hESC as
an antigen transferred from culture media containing ani-
mal-derived materials [20]. Accordingly, the serum
replacement medium used in the present experiments
contained bovine serum glycoproteins. We have recently
detected Neu5Gc in N-glycans of hESC and in vitro cul-
tured human mesenchymal stem cells by mass spectro-
metric N-glycan analysis [21].
The four hESC lines shared the same overall N-glycan pro-
file and there was only slight cell line specific variation
within the profiles. The 30 most common N-glycan sig-
nals were the same in all the hESC lines and accounted for
circa 85% of the total detected N-glycans. Similarly, EBs
derived from each hESC line produced N-glycan patterns
with similar characteristics, regardless of the different
starting hESC line.
Changes in the N-glycan profile during hESC 
differentiation
A major goal of the present study was to identify glycan
structures that would be specific to either stem cells or dif-
ferentiated cells, and could therefore serve as differentia-
tion stage markers. In order to determine whether the
hESC N-glycome undergoes changes during differentia-
tion, the N-glycan profiles obtained from hESC, EB, and
stage 3 differentiated cells were compared (Fig. 1B and
2B). The profiles of the differentiated cell types (EB and
stage 3 differentiated cells) were clearly different com-
pared to the profiles of undifferentiated hESC, as indi-
cated by non-overlapping distribution bars in many
glycan signals. This suggested that differentiation induced
the appearance of new N-glycan types while earlier glycan
types disappeared.
Figure 3 presents the observed sample-to-sample variation
in relative abundance of four N-glycan signals:
S1H5N4F2, S1H5N4F1, and H9N2 (hESC-associated), as
well as S1H5N5F1 (differentiated cell-associated).
S1H5N4F2 (Fig. 3A) was the major hESC-specific glycan
signal and had high abundance in all the four hESC lines,
while its relative amount dropped consistently in all sam-
ples from both EB and further differentiated cells. In con-
trast, S1H5N5F1 (Fig. 3B) that was the major
differentiation-associated glycan signal, was highly abun-
dant in all EB and further differentiated cell samples,
while it was only a minor glycan in all hESC samples.
These two glycan signals could serve as markers of either
the stem cells or the differentiated cells, respectively. TheBMC Cell Biology 2009, 10:42 http://www.biomedcentral.com/1471-2121/10/42
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Sample-to-sample comparison of relative signal intensities of four major N-glycan signals Figure 3
Sample-to-sample comparison of relative signal intensities of four major N-glycan signals. Sample-to-sample com-
parison of relative signal intensities of four major N-glycan signals in the whole dataset of four hESC lines (FES 21, FES 22, FES 
29, and FES 30), embryoid bodies derived from them (EB), stage 3 differentiated cells (st.3), and two human fibroblast samples 
from the same cell line that was used as feeder cells in the propagation of hESC. A. Glycan signal S1H5N4F2 is characteristic to 
hESC. B. Glycan signal S1H5N5F1 is characteristic to differentiated cells. C. and D. The major N-glycan signals S1H5N4F1 
(C.) and H9N2 (D.) are abundantly expressed in hESC and show variable expression in the differentiated cell types. Asterisks 
mark statistical significant differences between sample groups according to one-way ANOVA (p < 0.05).BMC Cell Biology 2009, 10:42 http://www.biomedcentral.com/1471-2121/10/42
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relative signal intensities of both S1H5N4F1 (Fig. 3C) and
H9N2 (Fig. 3D) were on average slightly higher in hESC
than in the differentiated cells, but individual differenti-
ated cell samples differed greatly from the average. These
glycan signals may therefore not be useful differentiation
stage markers as such, but may however indicate trends in
glycan biosynthesis.
The major differentiation stage associated N-glycan signal
types were also visualized in the sialylated N-glycan pro-
files (Fig. 2B). There was a significant hESC association in
the glycans S1H5N4F2 (Fig. 3A), S1H6N5F2, and
S1H5N4F3 as well as other glycan signals that contained
at least two deoxyhexose residues (F ≥ 2; marked with red
circles under Fig. 2B). Even minor signals with this struc-
tural feature were more abundant in hESC than in the dif-
ferentiated cell types. Sum of the relative signal intensities
of all F ≥ 2 N-glycan signals in Fig. 2B was 25% for hESC,
13% for EB, and 11% for stage 3 differentiated cells, indi-
cating that multifucosylation of sialylated N-glycans was
gradually decreased during hESC differentiation. Struc-
tural analysis of these glycans is presented in the following
section.
In contrast, a major group of N-glycan signals which
increased during differentiation contained equal amounts
of N-acetylhexosamine and hexose residues (N = H) in
their monosaccharide composition, e.g. S1H5N5F1 (Fig.
3B). This is consistent with N-glycan structures containing
non-reducing terminal N-acetylhexosamine residues. EB
and further differentiated cells showed increased amounts
of N-glycans expressing such monosaccharide composi-
tions (marked with gray circles under Fig. 2B). Sum of the
relative signal intensities of all N = H N-glycan signals in
Fig. 2B was 3% for hESC, 14% for EB, and 22% for stage
3 differentiated cells, indicating that this structural feature
was drastically increased during hESC differentiation at
the EB stage and then further increased in stage 3 differen-
tiated cells. However, these glycan structures were not
characterized further in the present study.
Of the three sample types, only hESC were grown in the
presence of hEF feeder cells, while both EB and further dif-
ferentiated cells were grown without hEF. Therefore the
observed hESC-specific glycans could have been contami-
nants derived from hEF. Figure 3 clearly shows that this
was not true for the major hESC-associated glycan signal
S1H5N4F2 (Fig. 3A) that had very low abundance in both
analysed hEF samples. Similar examination of other
hESC-associated glycans was consistent with this and we
could conclude that any potential hEF-derived contami-
nation was too minor to be detected. The major glycan
structures that we identified to be associated with either
the stem cells or the differentiated cells were not detected
in the potential contamination sources. These structures
included the major N-glycan signals with monosaccharide
compositions indicating complex fucosylation and termi-
nal HexNAc, for example the glycan signals shown in Fig.
3A–B. These signals were also undetectable in the cell cul-
ture media and supplements (data not shown).
The N-glycan profiles of the differentiated cells were also
quantitatively different from the undifferentiated hESC
profiles. A practical way of quantifying the differences
between glycan profiles was to calculate the sum of the
signal intensity differences between two samples. Accord-
ing to this method, the EB neutral and sialylated N-glycan
profiles had undergone a quantitative change of 14% and
29% from the hESC profiles, respectively. Similarly, the
stage 3 differentiated cell neutral and sialylated N-glycan
profiles had changed by 15% and 43%. Taking into
account that the proportion of neutral to sialylated N-gly-
cans in hESC was approximately 2:1, the total N-glycan
profile change was approximately 1/4 during the transi-
tion from hESC to stage 3 differentiated cells. The present
data thus indicated that the mass spectrometric profile of
the hESC N-glycome consisted of two discrete parts
regarding propensity to change during hESC differentia-
tion – a constant part and a changing part. As described
above, even the minor signals reflected the differentiation
stage associated N-glycan structural features. Therefore the
mass spectrometric profile in itself was a specific and sen-
sitive marker of hESC differentiation stage.
Statistical analysis of N-glycan profiles
To evaluate statistical differences between hESC and dif-
ferentiated cell N-glycan profiles, we performed one way
ANOVA for each glycan signal (see Additional File 1). The
analysis indicated statistical significance for the hESC-
associated N-glycan signals, e.g. large high-mannose type
N-glycan signals H7N2, H8N2, and H9N2, as well as com-
plex fucosylated N-glycan signals H5N4F2, S1H5N4F2,
and S1H5N4F3.
Factor and correlation analyses were employed in order to
find common factors which could explain the observed
distribution of N-glycan signals between the different cell
types. The analyses were performed separately to the neu-
tral N-glycans and acidic N-glycans (data not shown).
Observation of the resulting factors indicated structure
type related clustering of glycan signal groups in each fac-
tor. For example, major contributing signals in Factor N1
(explaining 26% of all variation in the neutral N-glycan
fraction) reflected the balance between hESC-associated
large high-mannose type N-glycans (H7N2, H8N2); and
differentiation-associated low-mannose type N-glycans
(H2N2, H3N2, H4N2), whereas Factor N2 (15%) was
dominated by differentiated cell types associated glycan
types: complex-type N-glycans with N = H type non-
reducing terminal HexNAc (H5N5, H5N5F1) and hybrid-BMC Cell Biology 2009, 10:42 http://www.biomedcentral.com/1471-2121/10/42
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type N-glycans (H5N3, H5N3F1, H6N3). Correlation
analysis indicated correlation among the large high-man-
nose type N-glycan signals (H6N2, H7N2, H8N2) and
negative correlation with the small high-mannose type N-
glycan H5N2.
In acidic glycan factor analysis, Factor A1 (explaining 24%
of all variation in the acidic N-glycan fraction) reflected
balance between 1) differentiated cell associated hybrid-
type N-glycan signals (S1H5N3F1, S1H6N3) and 2) hESC
associated complex-type N-glycans (S1H6N5F1,
S1H7N6F1, S1H8N7F1) and complex-fucosylated glycans
(S1H7N6F3). The major contributing signals in both Fac-
tors A2 and A3 (together explaining 23% of all variation
in the acidic fraction) were N = H type terminal HexNAc
bearing glycans (S1H5N5, S1H5N5F1, S2H5N5F1,
S1H5N5F3, S1H6N6F1, S2H6N6F1).
In conclusion, the performed statistical analyses demon-
strated that N-glycosylation changes during hESC differ-
entiation were regulated so that the glycan biosynthetic
changes were consistently similar from cell line to cell
line, which was directly reflected in the level of cellular N-
glycan profiles and even distinct glycan signals.
Structural analyses of the major hESC N-glycans
The N-glycan fractions were further analyzed by proton
NMR spectroscopy recorded from N-glycans isolated from
a larger sample of hESC grown on mEF. The assigned N-
glycan structures are included in Figure 4 (for details see
Additional File 1, Supplementary Fig. 3 and Supplemen-
tary Tables 1 and 2). In the obtained NMR spectrum of the
hESC neutral N-glycans, signals consistent with large
Man6-Man9 high-mannose type N-glycans were detected.
No evidence of other structures was found since the high-
mannose type N-glycan structures could explain all sig-
nals in the spectrum. In similar analysis of the sialylated
N-glycan fraction, all the detected signals were consistent
with biantennary complex-type N-glycans with type 2 N-
acetyllactosamine (LacNAc) antennae, α2,6- and α2,3-
linked sialic acids, and α1,6-linked N-glycan core fucose
modifications. No signals corresponding to type 1 LacNAc
antennae or other fucose linkages were detected. It was
determined by integration of indicator signals that α2,6-
linked sialic acids were more abundant than α2,3-linked
sialic acids.
In order to validate glycan structure assignments made
based on the mass spectrometric and NMR spectroscopic
profiling analyses, we performed enzymatic degradation
experiments with subsequent mass spectrometric detec-
tion (Fig. 4). Comparison of the original and digested N-
glycan profiles allowed estimation of the relative propor-
tions of non-reducing terminal monosaccharide residues
of neutral N-glycans characteristic of hESCs (Fig. 4A). α-
mannose residues were the most common terminal resi-
dues in the neutral glycan fraction, occurring in high-
mannose type, low-mannose type, and hybrid-type N-gly-
can signals. β1,4-linked galactose residues occurred in
hybrid-type and complex-type N-glycans, whereas termi-
nal β1,3-linked galactose residues were not detected. Non-
reducing terminal β-N-acetylglucosamine,  α1,2-fucose,
and α1,3- or α1,4-linked fucose residues were also present
in minor glycan components (data not shown), but not in
the major N-glycan signals presented in Figure 4.
The abundances of the major glycan signals in hESC and
EB are indicated in Figure 4 and show distinct features in
stem cells and differentiated cells. Most specifically, high-
mannose type N-glycans were associated with hESC, while
low-mannose type and hybrid-type N-glycans were more
abundant in EB. These differences suggest that regulation
of N-glycan biosynthetic pathways is changed during
hESC differentiation. We are currently studying the poten-
tial regulatory mechanisms leading to these N-glycan pro-
file differences (TJ et al., manuscript in preparation). The
observation of abundant low-mannose type N-glycans is
interesting. We observed comparable amounts of fuco-
sylated and non-fucosylated low-mannose type N-glycans
in both hESCs and EBs, while analyses of the culture
media revealed that they contained only non-fucosylated
N-glycans. This indicates that these structures were pro-
duced by the studied cells and they did not originate from
culture medium glycoproteins.
Analysis of complex fucosylation in N-glycans of hESC
As noted above, there was a significant hESC association
in N-glycans containing at least two deoxyhexose residues
(F ≥ 2; see Fig. 2B). In contrast, glycan signals such as
S2H5N4 that contained no deoxyhexose (F = 0) were
increased in the differentiated cell types. This suggested
that sialylated N-glycans in undifferentiated hESC were
subject to more fucosylation than in the differentiated cell
types. The most common fucosylation type in human N-
glycans is α1,6-fucosylation of the N-glycan core structure
[22] and this was also the major type of fucosylation
detected in the present NMR profiling. In human N-gly-
cans containing more than one fucose residue there
should be other fucose linkages in addition to the α1,6-
linkage [22,23], indicating complex fucosylation. The F ≥
2 structural feature decreased as the cells differentiated,
showing that complex fucosylation was characteristic of
undifferentiated hESC.
Exoglycosidase analysis of the sialylated N-glycan frac-
tions was performed with specific α1,2- and α1,3/4-
fucosidase enzymes to characterize the major hESC-spe-
cific N-glycan signals with complex fucosylation (Fig. 5A).
Based on the sensitivity of the signal S1H5N4F2 towards
the employed fucosidase enzymes, it was shown toBMC Cell Biology 2009, 10:42 http://www.biomedcentral.com/1471-2121/10/42
Page 9 of 18
(page number not for citation purposes)
Proposed structures for 20 most abundant N-glycan signals detected in the present study Figure 4
Proposed structures for 20 most abundant N-glycan signals detected in the present study. Proposed structures 
for 20 most abundant N-glycan signals detected in the present study (13 neutral and 7 sialylated N-glycans) are based on com-
bined results from MALDI-TOF mass spectrometry, proton NMR spectroscopy (NMR), and exoglycosidase analyses with α-
mannosidase (αMan), β1,4- and β1,3-galactosidase (β4Gal), β-N-acetylglucosaminidase, specific α1,3/4- and α1,2-fucosidases 
(α3/4Fuc and α2Fuc), and broad-range sialidase (SA). Relative abundances in hESC and EB N-glycan profiles are indicated. Only 
the positive identifications in 1H-NMR analyses and sensitivity to specific exoglycosidase digestions have been marked. Mon-
osaccharide symbols are as in Figure 1. Where appropriate, glycosidic bonds have been indicated. Two simplifying assumptions 
have been made: i) in structures with H ≥ 3 and N ≥ 2, the proposed structures have been assigned a trimannosyl core struc-
ture, and ii) all fucosylated structures have been assigned a core fucose residue.BMC Cell Biology 2009, 10:42 http://www.biomedcentral.com/1471-2121/10/42
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Analysis of major complex fucosylated N-glycans of hESC Figure 5
Analysis of major complex fucosylated N-glycans of hESC. A. The major sialylated N-glycan signal with complex fuco-
sylation feature (S1H5N4F2) was subjected to exoglycosidase sequencing with linkage-specific fucosidases and broad-range sial-
idase. As outlined in the reaction scheme, the signal was shown to be an approximately 1:1 mixture of α1,2- and α1,3-/α1,4-
fucosylated biantennary complex-type N-glycans with core fucosylation. B. and C. The acidic N-glycan fraction was permeth-
ylated and subjected to MS/MS fragmentation. Both S1H5N4F2 (B.) and S1H5N4F1 (C.) produced fragments that supported 
the structure assignments as indicated in the schematic drawings. D. The studied hESC lines were shown to express four of the 
known human fucosyltransferases. Minimal glycan acceptor and product specificities for the encoded enzymes are shown in the 
schematic drawing.BMC Cell Biology 2009, 10:42 http://www.biomedcentral.com/1471-2121/10/42
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include a mixture of isomeric N-glycan structures. Nearly
half of the structures within S1H5N4F2 carried one termi-
nal α1,2-linked fucose residue, while the other half car-
ried one terminal α1,3- or α1,4-linked fucose residue.
α1,3/4-fucosidase had a larger effect after desialylation
(data not shown), indicating that in minor structures
there was a fucose residue located subterminal to sialic
acid. The majority of the structures contained exactly one
fucose residue that was not susceptible to the employed
fucosidase treatments, indicating fucosylation in the N-
glycan core sequence. This was consistent with the NMR
results showing that N-glycan core α1,6-fucosylation was
the most abundant fucose linkage in hESC N-glycans. All
detected desialylated and defucosylated N-glycans of
hESC were sensitive to β1,4-galactosidase but not to β1,3-
galactosidase digestion, indicating that the major N-gly-
can antennae were type 2 LacNAc. Taken together, the
results suggested that the fucosylated antennae were either
α1,2-fucosylated H type 2 i.e. Fucα1-2Galβ1-4GlcNAc or
α1,3-fucosylated Lex i.e. Galβ1-4(Fucα1–3)GlcNAc. Due
to limited abundance of the minor structure with fucose
residue subterminal to sialic acid, we were not able to
sequence it, although a candidate structure is sLex i.e.
Neu5Acα2-3Galβ1–4(Fucα1-3)GlcNAc.
MS/MS fragmentation analysis was applied to the most
abundant hESC N-glycans with differential fucosylation,
S1H5N4F2 (Fig. 5B) and S1H5N4F1 (Fig. 5C). The frag-
mentation patterns supported the exoglycosidase diges-
tion and proton NMR profiling results and were
consistent with sialylated biantennary complex-type N-
glycans with predominant core fucosylation. Fucosylated
antennae derived from S1H5N4F2 were represented by a
single fragment ion at m/z 660.3 that fits to both H type 2
and Lex terminal structures (Fig. 5B), while fragment ions
corresponding to sLex were not detected.
Previously the gene expression profiles of the FES hESC
lines have been determined [24] and we extracted the
information of the expressed fucosyltransferases from this
data (Fig. 5D). The hESCs expressed fucosyltransferase
genes FUT1, FUT2, FUT4, and FUT8. Of these genes, FUT1
and FUT4 were overexpressed in hESC when compared to
EB. As shown in Figure 5D, in N-glycans expressing type 2
LacNAc antennae (Galβ1-4GlcNAc) the functional expres-
sion of the corresponding glycosyltransferase enzymes
may produce the following fucosylated epitopes: H type 2
(FUT1), Lex and sLex (FUT4), Ley (combined action of
FUT1 and FUT4), as well as N-glycan core α1,6-fucosyla-
tion (FUT8). Structures corresponding to Ley  (difuco-
sylated LacNAc) were not observed in the present study.
Taken together, the evidence indicated that the major fuc-
osylated epitopes in hESC N-glycans were H type 2 and
Lex, and additional minor sialylated and fucosylated struc-
tures were most likely sLex. However, based on the present
experiments it could not be excluded that minor Ley or
type 1 structures could be present in hESC N-glycans.
The identified hESC glycans can be targeted at the cell 
surface
From a practical perspective stem cell research would be
best served by reagents that recognize cell-type specific tar-
get structures on cell surface. To investigate whether indi-
vidual glycan structures we had identified would be
accessible to reagents targeting them at the cell surface, we
performed lectin labeling of three candidate structure
types. Lectins are proteins that recognize glycans with spe-
cificity to certain glycan structures. Previous studies have
extensively described lectin labeling of hESC [25-27] and
we have also initiated a study of lectin and glycan anti-
body ligands on hESC surfaces (MM et al., manuscript in
preparation). In the present study, hESC colonies grown
on mouse feeder cell layers were labeled in vitro by fluo-
rescein-labelled lectins (Fig. 6). The hESC cell surfaces
were clearly labeled by Maackia amurensis agglutinin
(MAA) that recognizes structures containing α2,3-linked
sialic acids, preferably α2,3-sialylated LacNAc, indicating
that such sialylated glycans were abundant on the hESC
cell surface (Fig. 6A). In contrast, the cell surfaces were not
labelled by Pisum sativum agglutinin (PSA) that recognizes
α-mannosylated glycans and potentially also core fuco-
sylated N-glycans (Fig. 6B). However, PSA labelled the
cells after permeabilization (data not shown). Finally,
Ulex europaeus agglutinin I (UEA-I) that recognizes fuco-
sylated structures, especially H type 2, stained hESC sur-
faces (Fig. 6C). The specificity of the lectin bindings was
validated by inhibition with specific glycan inhibitors as
described in the Methods section. Interestingly, the mouse
fibroblast cells showed complementary staining patterns
compared to hESC, suggesting that these lectin reagents
efficiently discriminated between hESC and feeder cells.
Figure 6D shows the FACS results with UEA-I further dem-
onstrating that hESC were highly positive for complex fuc-
osylated glycans including H type 2 terminal fucosylated
sequences. Consistent with the lectin labeling results, the
present structural analyses also demonstrated that both
complex fucosylated structures including H type 2 and
α2,3-sialylated LacNAc were abundant terminal structures
in hESC N-glycans. The results further suggested that the
identified glycan structures could be utilized to select rea-
gents specifically targeting undifferentiated hESC, while
not binding to other cell types. Glycans expressed on the
hESC surface would be good targets for recognition by
specific antibodies, which is subject of ongoing research
in our laboratories.
Discussion
In the present study, mass spectrometric and NMR spec-
troscopic analysis methods were applied in the first struc-
tural analysis of hESC N-glycan profiles. Previously, theBMC Cell Biology 2009, 10:42 http://www.biomedcentral.com/1471-2121/10/42
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glycosylation of hESC has been studied with lectins and
antibodies [25-27], and a preliminary report has been
published on mass spectrometric profiling of mouse
embryonic stem cell (mESC) N-glycans [28]. The objec-
tive in the present study was to provide a global view on
the N-glycan profile, or a "fingerprint" of hESC N-glyco-
sylation, to structurally characterize the most abundant N-
glycan structures of hESC, and to compare hESC N-glyco-
sylation with differentiated cells. The hESC N-glycome
was found to be characteristic to the cell type and different
from either differentiated human cells or mESCs. The data
provided information regarding the most characteristic
features of hESC N-glycosylation and demonstrated that a
dramatic N-glycan profile change takes place during hESC
differentiation.
Over one hundred N-glycan signals were detected from
each cell type. However, it is important to realize that
many of the mass spectrometric signals in the present
analyses include multiple isomeric structures and the one
hundred most abundant signals therefore represent a
larger amount of different glycans. The major N-glycans
observed in hESC covered all the major N-glycan classes,
namely oligomannose-type, hybrid-type, and complex-
type N-glycans [29], and were decorated with sialylated
and fucosylated antennae with equal complexity in all dif-
ferentiation stages. This directly demonstrated that stem
cell N-glycosylation was already as sophisticated as in the
differentiated cells.
Lectin staining of hESC colonies grown on mouse feeder cell layers Figure 6
Lectin staining of hESC colonies grown on mouse feeder cell layers. A. Maackia amurensis agglutinin (MAA) that rec-
ognizes α2,3-sialylated glycans, preferably in type 2 LacNAc, stained hESC but not feeder cell surfaces. B. Pisum sativum aggluti-
nin (PSA) that recognizes α-mannosylated glycans and core fucosylated N-glycans, stained only mouse feeder cell surfaces. C. 
Ulex europaeus agglutinin I (UEA-I) that recognizes α1,2-fucosylated glycans preferably within H type 2, stained the hESC col-
ony. Mouse fibroblasts had complementary staining patterns with the lectins, indicating that their surface glycans are clearly dif-
ferent from hESC. D. Fluorescence-assisted cell sorting (FACS) diagrams of UEA-I selected hESC, showing that the majority of 
hESC were positive for cell surface UEA-I ligands.BMC Cell Biology 2009, 10:42 http://www.biomedcentral.com/1471-2121/10/42
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We found that the hESC N-glycan profile contained both
a constant part and a variable part. The variable part was a
sensitive indicator of the differentiation commitment.
The major glycan types in the constant part were high-
mannose type and biantennary complex-type N-glycans.
The most characteristic feature of the variable part of the
hESC N-glycome was complex fucosylation. In fact, it was
found that 26% of the acidic N-glycan signals detected in
hESC were multifucosylated. On the other hand, structur-
ally different glycan structures were favoured by the differ-
entiated cell types. About 1/4 of the total N-glycan profile
of hESC changed during their differentiation. This dem-
onstrated that during differentiation hESC substantially
changed the appearance of their glycocalyx. New N-glycan
features emerged in EB and further differentiated cells.
These features included additional N-acetylhexosamine
residues, potentially leading to completely new glycan
epitopes presented on the differentiated cell surface. Such
drastic changes in the N-glycome may profoundly alter
both cell-cell interactions and the cells' responses to exog-
enous signals.
Glycans perform their functions in cells by acting as lig-
ands for specific glycan receptors [30-32], functioning as
structural elements of the cell [30], and modulating the
activity of their carrier proteins and lipids [2]. More than
half of all proteins in a human cell are glycosylated [3].
Consequently, a global change in protein-linked glycan
biosynthesis can simultaneously modulate the properties
of multiple proteins. It is likely that the large changes in
N-glycans during hESC differentiation have major influ-
ences on a number of cellular signaling cascades and affect
in profound fashion biological processes within the cells.
The major hESC-specific N-glycosylation feature we iden-
tified was complex fucosylation. Fucosylation is known to
be important in cell adhesion and signalling events
[22,23] as well as being essential for embryonic develop-
ment [23]. Knock-out of the N-glycan core α1,6-fucosyl-
transferase gene FUT8 leads to postnatal lethality in mice
[33], and mice completely deficient in fucosylated glycan
biosynthesis do not survive past early embryonic develop-
ment [34]. Fucosylated glycans such as the SSEA-1 anti-
gen, a special form of Lex [35-37], have previously been
associated with both mESC and human embryonic carci-
noma cells [15]. However, SSEA-1 is not expressed by
hESC, which has previously been interpreted such that
hESC would not express Lex. A recent report has suggested
that mESC proliferation and differentiation can be influ-
enced via specific recognition of fucosylated and sia-
lylated glycoconjugates in a mESC line transfected with L1
receptor [56].
The published gene expression profiles for the same hESC
lines as studied here [24] have demonstrated that four
human fucosyltransferase genes, FUT1, FUT2, FUT4, and
FUT8 are expressed in hESC (Fig. 5D), and that FUT1 and
FUT4 are overexpressed in hESC when compared to EB (TJ
et al., manuscript in preparation). FUT8 encodes the N-
glycan core α1,6-fucosyltransferase whose product was
identified as the major fucosylated epitope in hESC N-gly-
cans by the NMR analysis. The hESC-specific expression of
FUT1 and FUT4, encoding for α1,2-fucosyltransferase and
α1,3-fucosyltransferase enzymes, respectively [38], corre-
lates with our findings of simple fucosylation in EB and
complex fucosylation in hESC. The hESC-expressed
enzyme product of FUT2  (Secretor) may primarily be
linked to other glycan classes such as O-glycans or glycol-
ipids based on its preference for type 1, 3, and 4 chains not
detected in N-glycans (MM et al., manuscript in prepara-
tion). Interestingly, the FUT4-encoded enzyme is capable
of synthesizing both Lex, sLex, and SSEA-1, although the
capability to synthesize sLex may be low [39,40]. We
detected N-glycan antenna structures consistent with Lex
in hESC N-glycans. Consistent with this, Lex has been
reported to be present in mESC N-glycans [28]. N-glycan
signals potentially corresponding to sLex were detected in
very low amounts in hESC, which is consistent with the
reported specificity of the FUT4-encoded enzyme [39,40].
Our finding of H type 2 structures in hESC N-glycans is a
novel feature that differentiates hESC from mESC. How-
ever, Wearne et al. [26] have already reported α1,2-fuco-
sylation in hESC by utilizing UEA-I lectin staining.
Significantly, product of the hESC-overexpressed fucosyl-
transferase FUT1 (H enzyme) is mainly responsible for H
type 2 antigen biosynthesis (Fig. 5D). In conclusion,
although hESC do not express the specific fucosylated
antigen recognized by the SSEA-1 antibody, they share
with mESC the characteristic features of complex fucosyla-
tion and expression of the Lex antigen. The functions of
these major fucosylation modifications in hESC remain to
be elucidated in future studies. The present results suggest
that the SSEA-1 antibody does not recognize Lex when
when presented on a biantennary N-glycan antenna.
Human embryonic stem cell lines have previously been
demonstrated to have a common genetic stem cell signa-
ture that can be identified using gene expression profiling
techniques [41-44]. Such signatures have been proposed
to be useful in hESC characterization. In the present
report we provide the first glycan profile signatures for
hESC. The profile of the expressed N-glycans might be a
useful tool for analyzing and classifying the differentia-
tion stage in association with gene and protein expression
analyses. In the present work we demonstrated that mul-
tiple mass spectrometric glycan signals correlated with the
differentiation stage of hESC (Fig. 3). The present results
suggest that N-glycan profiling could be developed into a
tool for monitoring hESC differentiation status. Glycan
profiling might be more sensitive than the use of any sin-BMC Cell Biology 2009, 10:42 http://www.biomedcentral.com/1471-2121/10/42
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gle cell surface marker and especially useful for the quality
control of hESC-based cell products [21]. However, fur-
ther analysis of hESC glycans may also lead to establishing
new glycan structures as stem cell markers in addition to
the commonly used SSEA and Tra glycan structures.
The present lectin staining experiments demonstrated that
specific glycan molecules were abundant on the cell sur-
face of hESC. The cell surface presentation of glycans
makes them excellent targets for development of cell type
specific recognition reagents. It seems plausible that
knowledge of the changing surface glycan epitopes may
be utilized as a basis in developing reagents and culture
systems that would allow improved identification, selec-
tion, manipulation, and culture of hESC and their prog-
eny. The present data allow rational selection and
evaluation of glycan-specific antibodies based on knowl-
edge of hESC glycan structures.
Venable et al. [25] and Wearne et al. [26,27] have exten-
sively characterized hESC and EB reactivity for different
lectins. Their results with MAA and UEA-I lectins confirm
the present results about the expression of cell type-spe-
cific glycan epitopes on undifferentiated hESC surface.
These previous studies may also provide cues for differen-
tiation-associated N-glycan changes that were not struc-
turally characterized in the present study. Venable et al.
[25] described that N-glycans modified by bisecting Glc-
NAc residues as detected by Phaseolus vulgaris erythroag-
glutinin (PHA-E) were enriched in cells that had low or
absent SSEA-4 staining, potentially indicating that such N-
glycan structures were early signs of hESC differentiation.
Wearne et al. [26] also found PHA-E ligands on differenti-
ated hESC. It could be hypothesized that part of the termi-
nal N-acetylhexosamine carrying N-glycans (e.g. N-
glycans with N = H structural feature, see Fig. 2B) found in
the present study to be associated with differentiation
cells, could be modified by bisecting GlcNAc. Although
specific N-glycan structural information is hard to extract
from lectin binding profiles, the data of these earlier
reports support our findings of abundant terminal α-
mannose and LacNAc residues, both α2,3- and α2,6-sia-
lylation, N-glycan core and peripheral fucosylation, as
well as the presence of biantennary as well as branched
complex-type N-glycans. However, specificities of individ-
ual plant lectins towards terminal mono-or oligosaccha-
ride epitopes are usually not well characterized and may
have multiple interpretations. Therefore the previous lec-
tin studies gave a useful impression of the terminal mon-
osaccharide epitopes but not exact structural information.
The present structural data including larger oligosaccha-
ride structures could have parallels with the prior data, but
one should also consider technical factors which may
explain differences or potentially cause artificial similari-
ties. These differences include e.g. cell culture conditions,
assay techniques, sample preparation, and differences
between the studied cell lines. For example, we have pre-
viously shown that minor cell culture reagents may cause
glycan contamination of stem cells [21].
By employing rapid purification and direct analysis of
non-derivatized glycans we demonstrated mass spectro-
metric N-glycan profiling of the scarce hESC samples, ena-
bling analysis of samples as small as 100 000 cells. In
many glycomic studies of mammalian cells and tissues
the isolated glycans have been derivatized (e.g. permeth-
ylated) prior to mass spectrometric profiling [45-48] or
chromatographic analysis [49]. However, we chose to
directly analyze the picomolar quantities of unmodified
glycans and high sensitivity was achieved while omitting
the derivatization and the subsequent additional purifica-
tion steps. This straightforward method could be widely
applicable to analysis and monitoring of stem cell lines.
We have recently applied the same method to human cord
blood hematopoietic cells [18] as well as human mesen-
chymal stem cells [50].
Stem cell glycosylation has been reported to be sensitive
to composition of the cell culture medium [20,21]. In the
present study, we analyzed all biological material in con-
tact with the cells to exclude potential contamination
sources. Since no cell type in the present study had identi-
cal cell culture conditions, we could not exclude the pos-
sibility that the observed profile differences were in part
influenced by differences in cell culture. However, our
data supports the conclusion that the major identified N-
glycan structural features were not dependent on changes
in either cell culture media or growth surface. hESCs and
EBs were grown in the same culture medium except that
bFGF was omitted from EB culture, while the major differ-
ence between hESC and EB culture was that hESC colonies
were grown on feeder cells and EBs in suspension. To ana-
lyze if different growth surfaces could affect cellular glyco-
sylation, we have compared N-glycan profiles of hESCs
grown on hEF, mEF, Matrigel, and a defined non-animal
growth support (MM et al., manuscript in preparation).
On all these surfaces, hESCs show an N-glycan profile typ-
ical to undifferentiated cells, including abundant complex
fucosylation (such as S1H5N4F2, Fig. 3A) and low termi-
nal HexNAc (such as S1H5N5F1, Fig. 3B). This suggests
that the identified hESC-associated N-glycan profile fea-
tures are not sensitive to changes in the growth surface. In
addition, human fibroblast feeder cells, grown together
with hESC, produce an N-glycan profile missing the key
identifying characteristics of hESC glycosylation (for
example complex fucosylation, Fig. 3A). Further, stage 3
differentiated cells grown as monolayers in different cul-
ture medium expressed the same differentiated cell associ-
ated structures as EBs (Fig. 1, 2, 3).BMC Cell Biology 2009, 10:42 http://www.biomedcentral.com/1471-2121/10/42
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Conclusion
Human embryonic stem cells have a characteristic N-gly-
can profile which undergoes major changes when the cells
differentiate. Information regarding the specific glycan
structures may be utilized in developing reagents for tar-
geting these cells and their progeny. Future studies inves-
tigating the developmental and molecular regulatory
processes resulting in the observed N-glycan profiles may
provide significant insight into mechanisms of human
development and regulation of glycosylation.
Methods
Human embryonic stem cell lines
Finnish hESC lines FES 21, FES 22, FES 29, and FES 30
were cultured as described previously [43]. Briefly, two of
the analysed cell lines were initially derived and cultured
on mouse embryonic fibroblast (mEF) feeders, and two
on human foreskin fibroblast (hEF) feeder cells. For the
present studies all of the lines were transferred on hEF
feeder cells and cultured in serum-free medium supple-
mented with Knockout serum replacement (Gibco). To
induce the formation of embryoid bodies (EB) the hESC
colonies were first allowed to grow for 10–14 days where-
after the colonies were cut in small pieces and transferred
on non-adherent Petri dishes to form suspension cultures.
The formed EB were cultured in suspension for the next 10
days in standard culture medium without bFGF. For fur-
ther differentiation (into stage 3 differentiated cells, St.3)
EB were transferred onto gelatin-coated culture dishes in
media supplemented with insulin-transferrin-selenium
and cultured for 10 days.
For N-glycan profiling, on average 100 000 cells were col-
lected mechanically from culture on hEF feeder cell layers,
washed five times with phosphate buffered saline, and
stored frozen until the analysis. In fluorescence-assisted
cell sorting (FACS) analyses 70–90% of cells from
mechanically isolated hESC colonies were typically Tra 1–
60 and Tra 1–81 positive (data not shown). The differen-
tiation protocol favours the development of neuroepithe-
lial cells while not directing the differentiation into
distinct terminally differentiated cell types [51]. Stage 3
cultures consisted of a heterogeneous population of cells
dominated by fibroblastoid and neuronal morphologies.
For more detailed structural analyses by NMR spectros-
copy and glycosidase digestions, up to 10 million hESC
were grown on mEF layers.
Glycan isolation
Asparagine-linked glycans were detached from cellular
glycoproteins by F. meningosepticum peptide:N-glycosi-
dase F digestion (Calbiochem) and purified as described
previously [18]. Briefly, the detached glycans were puri-
fied by sequential precipitation/extraction and solid-
phase extraction steps with miniaturized chromatography
columns of C18  silica, strong cation-exchange resin,
porous graphitized carbon, and for the sialylated glycans
also microcrystalline cellulose.
Mass spectrometry and data analysis
MALDI-TOF mass spectrometry was performed with a
Bruker Ultraflex TOF/TOF instrument (Bruker Daltonics,
Germany) essentially as described [50]. Relative signal
intensities of neutral and sialylated glycan components
were assigned based on their relative signal intensities in
the mass spectra when analyzed separately as the neutral
and sialylated N-glycan fractions [52-55]. We calculated
relative intensities for all detected glycan signals using the
Flexanalysis 3.0 software (Bruker Daltonics). The present
glycan profiles were extracted from the resulting signal
lists by removing the effect of isotopic pattern overlap-
ping, multiple alkali metal adduct signals, products of
elimination of water from the reducing oligosaccharides,
and other interfering mass spectrometric signals not aris-
ing from the original glycans in the sample. The resulting
glycan signals in the presented glycan profiles were nor-
malized to 100% to allow comparison between samples.
The relative amounts of each glycan signal are expressed as
"% of total profile" similarly as previously reported
[17,18,50]. The mass spectrometric fragmentation analy-
sis of permethylated glycans was performed using the
Bruker Ultraflex TOF/TOF instrument according to manu-
facturer's instructions.
Glycosidase analysis
Aliquots from the N-glycan fractions were subjected to
digestion with α-mannosidase from Jack beans (C. ensi-
formis; Sigma-Aldrich); β1,4-galactosidase, β-N-acetylglu-
cosaminidase, and α2,3-sialidase from S. pneumoniae;
broad-range sialidase from A. ureafaciens; and β1,3-galac-
tosidase, α1,3/4-fucosidase, and α1,2-fucosidase from X.
manihotis (all from Calbiochem). Reactions with approxi-
mately 1–10 pmol oligosaccharide aliquots were carried
out by overnight digestion at +37°C in 10 μl of 50 mM
sodium acetate buffer pH 5.5. The activities of the
enzymes in each reaction were optimised such that they
had the following substrate specificities in control reac-
tions:  α2,3-sialidase digested Neu5Acα2-3Galβ1-
4GlcNAc (Neu5Acα2-3LacNAc) but not Neu5Acα2-
6LacNAc; β-N-acetylglucosaminidase digested GlcNAcβ1-
3LacNAc but not GalNAcβ1-4GlcNAc; LacNAc but neither
Galβ1-3GlcNAc nor Galα1-3LacNAc were digested with
β4Gal; β1,3-galactosidase digested Galβ1-3GlcNAc; α1,3/
4-fucosidase digested Fucα1-3(Galβ1-4)GlcNAc (Lex) but
not Fucα1-2Galβ1-3GlcNAc;  α1,2-fucosidase digested
Fucα1-2Galβ1-3GlcNAc but not Lex; and α-mannosidase
digested the high-mannose type N-glycans in a standard
human N-glycan mixture. Digested glycan fractions were
purified for analysis by solid-phase extraction and ana-
lyzed by mass spectrometry as described above.BMC Cell Biology 2009, 10:42 http://www.biomedcentral.com/1471-2121/10/42
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NMR methods
The isolated glycans were purified for the analysis by gel
filtration high-pressure liquid chromatography in a col-
umn of Superdex peptide HR 10/30 (Amersham), with
water (neutral glycans) or 50 mM NH4HCO3 (sialylated
glycans) as the eluant at a flow rate of 1 ml/min. The elu-
ant was monitored at 214 nm. Oligosaccharide pools
were quantified against external standards N-acetylglu-
cosamine and N-acetylneuraminic acid. Prior to NMR
analysis the purified glycome fractions were repeatedly
dissolved in 99.996% deuterium oxide and dried to omit
H2O and to exchange sample protons. The 1H NMR spec-
tra at 800 MHz were recorded using a cryo-probe for
enhanced sensitivity [18].
Lectin binding
Fluorescein-labeled lectins used in lectin binding studies
were from EY Laboratories. Specificity of binding was con-
trolled by inhibition with 50 mM α3'-sialyllactose
(Kyowa Hakko Kogyo, Japan), 100 mM α-D-mannose
methyl glycoside (Sigma-Aldrich), and 100 mM L-fucose
(Danisco Sweeteners, Finland) for Maackia amurensis
agglutinin (MAA), Pisum sativum agglutinin (PSA), and
Ulex europaeus agglutinin-I (UEA-I), respectively. Fluores-
cence-assisted cell sorting (FACS) analyses were per-
formed essentially as described [18].
Statistical analysis
Normalized mass spectrometric N-glycan profile data
from hESC (n = 4), EB (n = 7), and stage 3 differentiated
cells (n = 6) were imported to Statistica 7.0 software
(StatSoft). If all or almost all data values were zero, the
corresponding signal was removed from the data set. In
one way ANOVA with Fisher LSD post hoc analysis and
Factor analysis signals having all or most of the values
zero in certain cell type were omitted. Whisker box plots
with means and standard deviations were developed and
screened to have an overall view of the data and to identify
mass peaks with variation between different cell lines or
differentiation stage. Factor analysis was performed by
principal component extraction; factor loadings were Var-
imax normalized and signals having factor loadings >0.62
and factors explaining >5% of variance were included into
the model. Pearson correlation analysis was performed
and correlations more than 0.7 or less than -0.7 were con-
sidered significant.
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